SMT202400514T1 - Polimorfi del composto antimicotico di triazolo pc945 - Google Patents

Polimorfi del composto antimicotico di triazolo pc945

Info

Publication number
SMT202400514T1
SMT202400514T1 SM20240514T SMT202400514T SMT202400514T1 SM T202400514 T1 SMT202400514 T1 SM T202400514T1 SM 20240514 T SM20240514 T SM 20240514T SM T202400514 T SMT202400514 T SM T202400514T SM T202400514 T1 SMT202400514 T1 SM T202400514T1
Authority
SM
San Marino
Prior art keywords
polymorphs
triazole compound
antifungal triazole
antifungal
compound
Prior art date
Application number
SM20240514T
Other languages
English (en)
Italian (it)
Inventor
Julian Northen
Christopher John Wallis
Gerald Steele
Suzanne Buttar
Osama Suleiman
John Mykytiuk
Jamie Marshall
Original Assignee
Pulmocide Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pulmocide Ltd filed Critical Pulmocide Ltd
Publication of SMT202400514T1 publication Critical patent/SMT202400514T1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
SM20240514T 2019-12-06 2020-12-04 Polimorfi del composto antimicotico di triazolo pc945 SMT202400514T1 (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1917867.2A GB201917867D0 (en) 2019-12-06 2019-12-06 Polymorphs
EP20824979.7A EP4069690B1 (en) 2019-12-06 2020-12-04 Polymorphs of triazole antifungal compound pc945
PCT/GB2020/053107 WO2021111142A1 (en) 2019-12-06 2020-12-04 Polymorphs of triazole antifungal compound pc945

Publications (1)

Publication Number Publication Date
SMT202400514T1 true SMT202400514T1 (it) 2025-01-14

Family

ID=69171938

Family Applications (1)

Application Number Title Priority Date Filing Date
SM20240514T SMT202400514T1 (it) 2019-12-06 2020-12-04 Polimorfi del composto antimicotico di triazolo pc945

Country Status (26)

Country Link
US (1) US12491182B2 (enExample)
EP (2) EP4069690B1 (enExample)
JP (1) JP2023505227A (enExample)
KR (1) KR20220110726A (enExample)
CN (1) CN114746415B (enExample)
AU (1) AU2020397613A1 (enExample)
BR (1) BR112022006259A2 (enExample)
CA (1) CA3155829A1 (enExample)
CL (1) CL2022001464A1 (enExample)
CO (1) CO2022007808A2 (enExample)
DK (1) DK4069690T3 (enExample)
ES (1) ES3000984T3 (enExample)
FI (1) FI4069690T3 (enExample)
GB (1) GB201917867D0 (enExample)
HR (1) HRP20250042T1 (enExample)
HU (1) HUE069799T2 (enExample)
IL (1) IL293401A (enExample)
LT (1) LT4069690T (enExample)
MX (1) MX2022006654A (enExample)
PL (1) PL4069690T3 (enExample)
PT (1) PT4069690T (enExample)
RS (1) RS66401B1 (enExample)
SA (1) SA522432879B1 (enExample)
SI (1) SI4069690T1 (enExample)
SM (1) SMT202400514T1 (enExample)
WO (1) WO2021111142A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6669751B2 (ja) 2014-12-05 2020-03-18 プルモシデ リミテド 抗真菌化合物
CN117510488B (zh) * 2022-07-28 2025-12-05 博瑞制药(苏州)有限公司 一种硫酸艾沙康唑的制备方法
CN117330660A (zh) * 2023-09-14 2024-01-02 广州医科大学附属第一医院(广州呼吸中心) Uplc-ms/ms联用检测艾沙康唑的方法及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1292472C (en) 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
EP0318214B1 (en) 1987-11-20 1994-12-14 Schering Corporation Tri- and tetra-substituted-oxetanes and -tetrahydrofurans and intermediates thereof
US5039676A (en) 1990-05-11 1991-08-13 Schering Corporation Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
HU225062B1 (en) 1993-12-21 2006-05-29 Schering Corp Tetrahydrofuran derivatives with antifungal- effect, pharmaceutical compositions containing them and process for their preparation
US5714490A (en) 1993-12-21 1998-02-03 Schering Corporation Tetrahydrofuran antifungals
US5486625A (en) 1994-07-08 1996-01-23 Schering Corporation Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents
CZ59497A3 (en) 1995-06-02 1997-08-13 Schering Corp Tetrahydrofuran derivative and pharmaceutical composition containing thereof
EP0957101A1 (en) 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals
EP1372394A1 (en) 2001-04-03 2004-01-02 Schering Corporation Antifungal composition with enhanced bioavailability
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
US9346791B2 (en) 2011-09-07 2016-05-24 The Johns Hopkins University Itraconazole analogs and use thereof
JP6669751B2 (ja) 2014-12-05 2020-03-18 プルモシデ リミテド 抗真菌化合物

Also Published As

Publication number Publication date
EP4069690B1 (en) 2024-11-13
PL4069690T3 (pl) 2025-03-10
DK4069690T3 (da) 2025-01-20
ES3000984T3 (es) 2025-03-04
FI4069690T3 (fi) 2025-01-21
US20230028714A1 (en) 2023-01-26
EP4069690A1 (en) 2022-10-12
CO2022007808A2 (es) 2022-06-30
MX2022006654A (es) 2022-09-07
CN114746415A (zh) 2022-07-12
JP2023505227A (ja) 2023-02-08
SA522432879B1 (ar) 2025-01-26
CA3155829A1 (en) 2021-06-10
CN114746415B (zh) 2025-04-11
US12491182B2 (en) 2025-12-09
PT4069690T (pt) 2024-12-13
CL2022001464A1 (es) 2023-03-24
SI4069690T1 (sl) 2025-03-31
LT4069690T (lt) 2025-01-10
IL293401A (en) 2022-07-01
BR112022006259A2 (pt) 2022-06-21
EP4509179A2 (en) 2025-02-19
GB201917867D0 (en) 2020-01-22
HRP20250042T1 (hr) 2025-03-14
HUE069799T2 (hu) 2025-04-28
AU2020397613A1 (en) 2022-06-02
KR20220110726A (ko) 2022-08-09
WO2021111142A1 (en) 2021-06-10
EP4509179A3 (en) 2025-02-26
RS66401B1 (sr) 2025-02-28

Similar Documents

Publication Publication Date Title
ZA202106194B (en) Fungicidal compounds
IL292753A (en) Compounds
DK3956033T3 (da) Bicykliske forbindelser
DK4083038T3 (da) Pyridazinylthiazolcarboxamidforbindelse
IL286833A (en) Compositions containing brazzein
GB201806578D0 (en) Novel compound
CL2016003145A1 (es) Compuestos de [1,2,4]triazol sustituido
IL280821A (en) Heterocycline compound
SI3802990T1 (sl) Obloga za spodnji ustroj tal
LT3823970T (lt) Papildomai pakeisti triazolo chinoksalino dariniai
SMT202400514T1 (it) Polimorfi del composto antimicotico di triazolo pc945
ZA202103684B (en) Novel imidazole derivative
ZA202104402B (en) Heterocyclic compound
SI3782986T1 (sl) Heterociklična spojina
EP4006037A4 (en) HETEROCYCLIC COMPOUND
IL285046A (en) Anti-apicomplexan compositions
EP4005637A4 (en) Heterocyclic compound
DK3762369T3 (da) Fremgangsmåde til fremstilling af fungicidt aktive triazolforbindelser
IL277340A (en) The orthocyclic compound
IT201900024033A1 (it) Struttura di calzatura
GB201919095D0 (en) Inhibitory compounds
GB201917603D0 (en) Inhibitory compounds
GB201912603D0 (en) Inhibitory compounds
UA40236S (uk) Органайзер для дрібних деталей
GB201904848D0 (en) Inhibitory compounds